Days after being approved for its first-in-human trials, Verismo’s SynKIR-110 immunotherapy drug has been granted orphan drug designation for the...
from Mesothelioma.net https://ift.tt/OgpIsHu
via IFTTT
from Mesothelioma.net https://ift.tt/OgpIsHu
via IFTTT
Orphan Drug Status Granted to Promising Mesothelioma Drug
Reviewed by Unknown
on
September 29, 2022
Rating:
No comments: